Tatva Chintan Pharma Chem's Stock Plummets, Receives 'Strong Sell' Rating from MarketsMOJO

Tatva Chintan Pharma Chem, a smallcap company in the chemical industry, has been facing a downward trend in its stock performance. On October 28, 2024, the company's stock lost -10.52%, resulting in a 'Strong Sell' call by MarketsMOJO. The stock opened with a loss of -5.43% and hit a new 52-week and all-time low of Rs. 818.3. It also underperformed the sector by -9.5% and has been on a consecutive fall for the last 2 days, with a -12.57% decline in returns during this period. The stock also touched an intraday low of Rs. 818.3, marking a -10.53% decrease. Tatva Chintan is currently trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a negative trend in its stock performance. In comparison to the Sensex, Tatva Chintan's 1-day performance is -10.51%, while the Sensex has shown a positive performance of 0.36%. Similarly, in the past month, Tatva Chintan's stock has declined by -19.96%, while the Sensex has shown a decline of -6.88%. Investors and experts are advised to closely monitor the performance of Tatva Chintan Pharma Chem and make informed decisions based on the company's financials and market trends.